You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 4,421,762

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 4,421,762

Title:	Method of treatment of an allergy to an ingested allergen
Abstract:	There is described a method of treatment of allergy to ingested allergens, which comprises per os administration of a daily dosage of from 20 to 4,000 mg of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane or a therapeutically acceptable salt thereof to a patient having such an allergy.
Inventor(s):	Wardell; George (Loughborough, GB2)
Assignee:	Fisons Limited (London, GB2)
Application Number:	06/300,281
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 4,421,762

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 4,421,762

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	6911/72	Feb 15, 1972
United Kingdom	4912/74	Feb 02, 1974

International Family Members for US Patent 4,421,762

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
United Kingdom	1423985	⤷ Try a Trial
Malaysia	7700009	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.